What Is a Clinical Trial and How Do You Join One?

Updated

A clinical trial is a research study in which people volunteer to test a medical intervention—a drug, device, procedure, or behavioral change—to answer questions about its safety and whether it works. You join one by finding a study that matches your condition, confirming you meet its eligibility criteria, and completing the study team's screening and informed consent process. Trials are not a guaranteed treatment: they are experiments, and participation always carries uncertainty. The sections below explain how trials are structured, how eligibility works, and what to ask before you enroll, using Neuralink's PRIME study of an implanted brain-computer interface as a concrete example.

What a clinical trial actually is

A clinical trial is a controlled experiment run under a written protocol—a document that specifies who can participate, what intervention they receive, how outcomes are measured, and how risks are monitored. Trials are typically sponsored by a company, university, hospital, or government agency and reviewed by an institutional review board (IRB) or ethics committee before any participant is enrolled.

The purpose is to generate evidence. A trial does not exist to deliver care to an individual; it exists to answer a question that can later inform care for many people. That distinction matters when you weigh whether to join.

The main phases

Phase Typical question Typical size What it means for you
Phase 1 Is it safe? What dose or setting is tolerable? Small (often dozens) Highest uncertainty; frequent monitoring
Phase 2 Does it show signs of working? Larger (hundreds) More data on benefit, still experimental
Phase 3 Does it work better than the current standard? Large (hundreds to thousands) Often the basis for regulatory approval
Phase 4 What happens after approval? Large, long-term Post-market safety and real-world use

Early-stage device trials often blend features of Phase 1 and Phase 2: the primary goal is safety and feasibility, with preliminary signals about function. Neuralink's PRIME study is described as an early-stage trial of an implanted brain-computer interface aimed at people with quadriplegia, paraplegia, or ALS—conditions where the goal is restoring some degree of control or communication rather than curing the underlying condition.

Why eligibility criteria are so specific

Every trial defines who may participate. Criteria usually include:

  • Condition and diagnosis — the specific disease, injury level, or functional status being studied.
  • Age and general health — to reduce confounding factors and risk.
  • Prior treatments — some trials exclude people who have already received a particular therapy.
  • Practical factors — ability to travel to the study site, attend follow-up visits, and comply with the protocol.

This is why trials target narrow groups such as people with quadriplegia or ALS. A device implanted in the brain must be tested in people whose condition matches the intended use, and the study team needs to interpret results without too many unrelated variables. If you do not meet the criteria, it is not a judgment about your case—it means the study was not designed to answer a question about someone like you.

Informed consent: what you are actually agreeing to

Informed consent is a process, not a signature. Before enrolling, the study team must explain:

  • The purpose of the trial and why you are being asked.
  • What procedures you will undergo, including surgery, imaging, or device implantation if applicable.
  • Known risks and the possibility of unknown risks.
  • Potential benefits, and the explicit statement that benefit is not guaranteed.
  • Alternatives to participating, including standard care.
  • Your right to withdraw at any time without losing access to other care.
  • How your data and biological samples will be used and shared.

You should be able to ask questions until you understand the tradeoffs, and you can take the consent form home before deciding. If anything is unclear, ask the study coordinator to walk through it again.

How to find trials and evaluate them

Start with registries and your own care team:

  1. Search a public registry. ClinicalTrials.gov (and equivalent national registries) lets you filter by condition, intervention, phase, and location. Read the "Eligibility Criteria" and "Contacts and Locations" sections carefully.
  2. Ask your specialist. Neurologists, physiatrists, and other specialists often know which trials are recruiting in your area or can refer you to a center.
  3. Contact the study team directly. Use the listed contact to ask whether you might qualify before investing time in travel or records.
  4. Read the protocol summary. Look for the primary outcome—what the study is actually measuring—and the follow-up schedule.

Questions to ask before enrolling

  • What is the primary goal of this trial—safety, feasibility, or effectiveness?
  • What procedures will I undergo, and how invasive are they?
  • How many visits are required, and over how long?
  • Who pays for the intervention, travel, and any complications?
  • What happens if the device or treatment does not work, or if I want to stop?
  • Will I be told results, and when?
  • What are the alternatives if I do not join?

Write the answers down. If a team cannot answer a basic question about risks or costs, that is useful information.

Risks, benefits, and the decision to join

Participating in a trial can offer access to an intervention before it is widely available, closer monitoring, and the chance to contribute to research that may help others. It can also mean unknown side effects, procedures that carry their own risks (especially with implanted devices), time commitments, and the possibility that the intervention does not help you.

For an early-stage device trial like PRIME, the surgical implantation of a brain-computer interface and the long-term presence of hardware are central considerations. Discuss with your own physician how the trial's procedures compare with your current care, and whether the potential benefits justify the risks for your situation. No one should feel pressured to enroll, and declining a trial does not close the door to future options.

A practical checklist

  • Confirm the trial is registered and recruiting.
  • Verify you meet the eligibility criteria before contacting the team.
  • Read the informed consent document in full and ask questions.
  • Clarify costs, travel, and follow-up obligations in writing.
  • Talk with your treating physician about how participation fits your care.
  • Know your right to withdraw at any time.

A clinical trial is a structured experiment, and joining one is a decision you make with full information—not a default next step. Use the registry, your care team, and the study's own documents to decide whether a specific trial is right for you.